• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.基因组测序和携带者检测:关于分类的决策以及是否披露携带者检测结果。
Genet Med. 2017 Jul;19(7):803-808. doi: 10.1038/gim.2016.198. Epub 2017 Jan 12.
2
Generating a taxonomy for genetic conditions relevant to reproductive planning.生成与生殖规划相关的遗传病症分类法。
Am J Med Genet A. 2016 Mar;170(3):565-73. doi: 10.1002/ajmg.a.37513.
3
Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing.患者对遗传疾病的评分验证了一种分类法,以简化通过基因组测序进行孕前携带者筛查的决策。
Am J Med Genet A. 2016 Mar;170(3):574-82. doi: 10.1002/ajmg.a.37477. Epub 2016 Jan 21.
4
Laboratory testing for preconception/prenatal carrier screening: A technical standard of the American College of Medical Genetics and Genomics (ACMG).孕前/产前携带者筛查的实验室检测:美国医学遗传学与基因组学学会(ACMG)的技术标准。
Genet Med. 2024 Jul;26(7):101137. doi: 10.1016/j.gim.2024.101137. Epub 2024 May 30.
5
Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results.患者对使用疾病类别进行基因组携带者筛查结果决策的看法。
Am J Med Genet A. 2018 Feb;176(2):376-385. doi: 10.1002/ajmg.a.38583. Epub 2017 Dec 18.
6
Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience.转化基因组学研究中携带者检测及结果披露的方法:临床测序探索性研究联盟的经验
Mol Genet Genomic Med. 2018 Nov;6(6):898-909. doi: 10.1002/mgg3.453. Epub 2018 Aug 21.
7
Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.200 名接受临床外显子组测序个体中,关于披露次要检测结果的患者决策。
Genet Med. 2014 May;16(5):395-9. doi: 10.1038/gim.2013.153. Epub 2013 Oct 10.
8
Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes.优化临床外显子组设计和隐性遗传疾病的平行基因检测在孕前携带者筛查中的应用:来自 14125 个外显子组的转化研究基因组数据。
PLoS Genet. 2019 Oct 7;15(10):e1008409. doi: 10.1371/journal.pgen.1008409. eCollection 2019 Oct.
9
Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing.使用基因组测序进行孕前扩展携带者筛查减少的原因。
J Genet Couns. 2017 Oct;26(5):971-979. doi: 10.1007/s10897-017-0074-y. Epub 2017 Mar 17.
10
Carrier testing for severe childhood recessive diseases by next-generation sequencing.下一代测序技术在严重儿童隐性疾病中的携带者检测
Sci Transl Med. 2011 Jan 12;3(65):65ra4. doi: 10.1126/scitranslmed.3001756.

引用本文的文献

1
Applications of genome sequencing as a single platform for clinical constitutional genetic testing.基因组测序作为临床先天性基因检测单一平台的应用。
Genet Med Open. 2024 Mar 20;2:101840. doi: 10.1016/j.gimo.2024.101840. eCollection 2024.
2
Opportunistic genomic screening has clinical utility: An interventional cohort study.机会性基因组筛查具有临床实用性:一项干预性队列研究。
Genet Med. 2025 Feb;27(2):101323. doi: 10.1016/j.gim.2024.101323. Epub 2024 Nov 9.
3
Prevalence of common autosomal recessive mutation carriers in women in the Southern Vietnam following the application of expanded carrier screening.在扩大携带者筛查后,越南南部女性中常见常染色体隐性遗传病携带者的流行率。
Sci Rep. 2024 Mar 29;14(1):7461. doi: 10.1038/s41598-024-57513-0.
4
Management considerations for clinically relevant findings on expanded carrier screening in a sperm donor applicant population.精子捐献申请者群体中扩大携带者筛查的临床相关发现的管理考量
F S Rep. 2023 Nov 2;4(4):384-389. doi: 10.1016/j.xfre.2023.10.005. eCollection 2023 Dec.
5
Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach.在普通人群中进行携带者筛查的临床经验:支持全面的泛种族方法。
Genet Med. 2020 Aug;22(8):1320-1328. doi: 10.1038/s41436-020-0807-4. Epub 2020 May 5.
6
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial.从加拿大癌症人群的基因组测序中返回偶然结果的健康结果、效用和成本:一项混合方法随机对照试验的方案。
BMJ Open. 2019 Oct 7;9(10):e031092. doi: 10.1136/bmjopen-2019-031092.
7
Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.责任、身份认同与基因组测序:已发表建议与患者对接受或拒绝偶然发现的观点之比较
Mol Genet Genomic Med. 2018 Nov;6(6):1079-1096. doi: 10.1002/mgg3.485. Epub 2018 Oct 28.
8
Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience.转化基因组学研究中携带者检测及结果披露的方法:临床测序探索性研究联盟的经验
Mol Genet Genomic Med. 2018 Nov;6(6):898-909. doi: 10.1002/mgg3.453. Epub 2018 Aug 21.
9
Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening.评估有意愿支付孕前携带者筛查的女性和夫妇对扩大携带者筛查的支付意愿。
PLoS One. 2018 Jul 18;13(7):e0200139. doi: 10.1371/journal.pone.0200139. eCollection 2018.
10
Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.孕前携带者筛查的基因组测序结果:临床实验室的研究。
Am J Hum Genet. 2018 Jun 7;102(6):1078-1089. doi: 10.1016/j.ajhg.2018.04.004. Epub 2018 May 10.

本文引用的文献

1
Prenatal Testing for Adult-Onset Conditions: the Position of the National Society of Genetic Counselors.成人发病疾病的产前检测:美国国家遗传咨询师协会的立场
J Genet Couns. 2016 Dec;25(6):1139-1145. doi: 10.1007/s10897-016-9992-3. Epub 2016 Jul 1.
2
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.临床测序探索性研究联盟:加速基于证据的基因组医学实践。
Am J Hum Genet. 2016 Jun 2;98(6):1051-1066. doi: 10.1016/j.ajhg.2016.04.011. Epub 2016 May 12.
3
Generating a taxonomy for genetic conditions relevant to reproductive planning.生成与生殖规划相关的遗传病症分类法。
Am J Med Genet A. 2016 Mar;170(3):565-73. doi: 10.1002/ajmg.a.37513.
4
Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing.患者对遗传疾病的评分验证了一种分类法,以简化通过基因组测序进行孕前携带者筛查的决策。
Am J Med Genet A. 2016 Mar;170(3):574-82. doi: 10.1002/ajmg.a.37477. Epub 2016 Jan 21.
5
Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process.儿科研究中研究结果及偶发发现反馈的原则声明:多中心协商过程
Genome. 2015 Dec;58(12):541-8. doi: 10.1139/gen-2015-0092. Epub 2015 Nov 10.
6
Genetic Counselors' Perspectives and Practices Regarding Expanded Carrier Screening after Initial Clinical Availability.基因咨询师对初始临床应用后扩展携带者筛查的观点与实践
J Genet Couns. 2016 Apr;25(2):395-404. doi: 10.1007/s10897-015-9881-1. Epub 2015 Sep 10.
7
It's complicated: criteria for policy decisions for the clinical integration of genome-scale sequencing for reproductive decision making.情况很复杂:生殖决策中基因组规模测序临床整合的政策决策标准
Mol Genet Genomic Med. 2015 Jul;3(4):239-42. doi: 10.1002/mgg3.130.
8
"Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening.“了解它是否值得?”焦点小组参与者对基因组孕前携带者筛查的感知效用
J Genet Couns. 2016 Feb;25(1):135-45. doi: 10.1007/s10897-015-9851-7. Epub 2015 Jun 21.
9
ClinGen--the Clinical Genome Resource.ClinGen——临床基因组资源。
N Engl J Med. 2015 Jun 4;372(23):2235-42. doi: 10.1056/NEJMsr1406261. Epub 2015 May 27.
10
Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine.生殖医学中的扩展携带者筛查:需要考虑的问题:美国医学遗传学与基因组学学院、美国妇产科医师学会、国家遗传咨询师协会、围产期质量基金会和母胎医学学会的联合声明。
Obstet Gynecol. 2015 Mar;125(3):653-662. doi: 10.1097/AOG.0000000000000666.

基因组测序和携带者检测:关于分类的决策以及是否披露携带者检测结果。

Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.

机构信息

Department of Medical Genetics, Kaiser Permanente Northwest, Portland, Oregon, USA.

Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.

出版信息

Genet Med. 2017 Jul;19(7):803-808. doi: 10.1038/gim.2016.198. Epub 2017 Jan 12.

DOI:10.1038/gim.2016.198
PMID:28079899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5509491/
Abstract

PURPOSE

We investigated the use of genome sequencing for preconception carrier testing. Genome sequencing could identify one or more of thousands of X-linked or autosomal recessive conditions that could be disclosed during preconception or prenatal counseling. Therefore, a framework that helps both clinicians and patients understand the possible range of findings is needed to respect patient preferences by ensuring that information about only the desired types of genetic conditions are provided to a given patient.

METHODS

We categorized gene-condition pairs into groups using a previously developed taxonomy of genetic conditions. Patients could elect to receive results from these categories. A Return of Results Committee (RORC) developed inclusion and exclusion criteria for each category.

RESULTS

To date, the RORC has categorized 728 gene-condition pairs: 177 are categorized as life span-limiting, 406 are categorized as serious, 93 are categorized as mild, 41 are categorized as unpredictable, and 11 are categorized as adult-onset. An additional 64 gene-condition pairs were excluded from reporting to patients or put on a watch list, generally because evidence that a gene and condition were associated was limited.

CONCLUSION

Categorization of gene-condition pairs using our taxonomy simplifies communication regarding patient preferences for carrier information from a genomic test.Genet Med advance online publication 12 January 2017.

摘要

目的

我们研究了使用基因组测序进行孕前携带者检测。基因组测序可以识别出数千种 X 连锁或常染色体隐性遗传病中的一种或多种,这些疾病可以在孕前或产前咨询中披露。因此,需要一个框架来帮助临床医生和患者了解可能的发现范围,通过确保只向特定患者提供所需类型的遗传疾病信息,来尊重患者的偏好。

方法

我们使用先前开发的遗传疾病分类法将基因-疾病对分类成组。患者可以选择接收这些类别的结果。一个回报结果委员会(RORC)为每个类别制定了纳入和排除标准。

结果

迄今为止,RORC 已经对 728 对基因-疾病进行了分类:177 对被归类为寿命受限,406 对被归类为严重,93 对被归类为轻度,41 对被归类为不可预测,11 对被归类为成年发病。另外 64 对基因-疾病对被排除在向患者报告或列入观察名单之外,通常是因为证据表明基因和疾病之间存在关联的证据有限。

结论

使用我们的分类法对基因-疾病对进行分类,简化了关于患者对基因组检测携带者信息偏好的沟通。遗传医学在线发表 2017 年 1 月 12 日。